At 00h30 a zebra snake (N. n. nigricinta) bit a 23yearold man in the face. He was asleep in his bed while staying at a lodge near This open-access article is distributed under Creative Commons licence CC-BY-NC 4.0.
IN PRACTICE
The World Health Organization added snakebite to the list of Neglec ted Tropical Diseases in 2009. Each year, snakebite affects the lives of around 4.5 million people worldwide, seriously injuring 2.7 million men, women and children, and claiming some 125 000 lives. [1] Namibia is one of the most sparsely populated countries in the world (population 2.5 million) and home to an abundance of wildlife, including snakes. [2] There is no official database on snakebite in Namibia. The Namibian Snakebite Interest Group (NSIG) is involved with ~10 20 zebra snake (Naja nigricincta nigricincta) envenomations annually (PJCB and ELS, members of NSIG, personal communication; Francois Theart, official snake rescue and anti poaching agent, personal communication).
N. n. nigricincta is a spitting cobra and is frequently encountered in Namibia. The distribution is mainly the central and northern regions of this country, and southern Angola. [3] The snake seems to be well adapted to populated areas, and it appears to lack any fear of humans. [4] As a result of 43 years of clinical involvement with snakebites in Namibia and clinical management of ~700 zebra snake bites, PJCB makes the following statements (personal communication): 'This spitting cobra has come to be particularly feared, especially by the rural communities, as the snake is nocturnal and commonly found inside dwellings in search of small rodents for prey. The majority of N. n. nigricincta bites have occurred at night while the victims were asleep. Although rarely fatal, the venom is highly cytotoxic with no neurotoxic symptoms or signs observed. [5] Antivenom seems to be ineffective in the treatment of envenomation. Without early, adequate, speedy surgical debridement, necrosis with extensive tissue loss, contractures, disfigurement and loss of function will almost always be the outcome. The only exception being bites in the face or genital areas, where a more conservative surgical approach seems merited. ' No clinical research on N. n. nigricincta bites has been done. Treatment in Namibia has been derived from the clinical experience mentioned above. It was supported by studies by Warrell et al. [6] on bites by N. nigricollis, a very close relative of N. nigricincta found in central Africa, with a remarkably similar symptom complex and outcome. [6] The Namibian experience and treatment stand in contrast with case studies done on N. mossambica. [7, 8] This spitting cobra is found in the more tropical regions of southern Africa, northern Namibia and southern Angola. [9] Although envenomation causes severe tissue necrosis with occasional drowsiness and respiratory depression, antivenom seems to be effective if given shortly after the bite, and delayed surgical intervention is advocated. [7, 8] The venom of N. mossambica is used in the production of our currently available polyvalent antivenom from South African Vaccine Producers (SAVP), [10] which may explain why the antivenom, given early, results in less necrosis. The venom of N. n. nigricincta is not used in the manufacturing of the South African Institute for Medical Research (SAIMR) polyvalent antivenom. [10] The severe cytotoxic effects and debilitating consequences of neglected bites of the zebra snake, as well as the lack of obvious systemic involvement in the majority of patients, have resulted in emphasis being placed on urgent treatment of the necrosis. However, over the years there have been a few marring reports of unexplained infant fatalities and renal failure following N. n. nigricinta bites. [11, 12] The authors have started renewed research on snakebites in Namibia, with the emphasis on N. n. nigricinta bites. The objective of this research is to establish evidencebased treatment protocols for all Namibian snakebites, especially those inflicted by N. n. nigricinta, and to compile a national snakebite database. During this research three patients were encountered who showed evidence of intravascular haemolysis, rhabdomyolysis and coagulopathy as well as severe tissue necrosis.
Etosha National Park. The patient was referred to the local snakebite specialist in Windhoek, where he arrived 7.5 hours after being bitten.
On admission he exhibited periorbital oedema, noticeably more severe on the right. Two fang marks, medial and inferior to the right eye with discoloration of the skin surrounding the fang marks and the upper eyelid, were noted. He complained of severe muscle pains in his back and legs.
On examination his vision and eye movements were normal. He was awake and orientated and showed no signs of muscle weakness, respiratory distress or cardiovascular compromise. Because he was stable, he was admitted to a general ward under the care of a general surgeon for initial conservative treatment and observation.
Laboratory results on day 1 were as follows: white blood cell count (WBC) 19.7 × 10 9 /L (neutrophil count 17.2 × 10 9 /L). The haemoglobin concentration (Hb) and urea and electrolytes (U&E) were normal. Unconjugated bilirubin was increased (57 µmol/L), with raised lactate dehydrogenase (LDH) (1 510 U/L), aspartate transaminase (AST) (675 U/L) and alanine transaminase (ALT) (86 U/L). Dipstick urinalysis showed 2+ blood in the urine.
On the second day a creatine kinase (CK) level was requested, which was elevated (96 900 U/L). LDH, AST and ALT were still high. Urine myoglobin and urine bilirubin were positive. Serum haptoglobin was very low (0.06 g/L) (normal 0.34 2.00 g/L).
The patient was treated with aggressive fluid management, analgesics and moxifloxacin (started on day 5). Although it is controversial, we give prophylactic antibiotics to all victims of cytotoxic snakebites. Studies in Taiwan and China underlined our clinical experience of a high incidence of secondary wound infections following cytotoxic bites, especially N. n. nigricincta bites, when no antivenom is given. [1317] The CK values peaked on day 3 (101 200 U/L) and gradually subsided over the following days. The international normalised ratio (INR), which peaked on day 2 (1.7), normalised without specific treatment. LDH peaked on day 3 (3 510 U/L). Hb decreased from 16.3 g/dL (day 1) to 14.1 g/dL (day 7). The cumulative report is shown in Table 1 .
Kidney function and electrolyte values stayed within normal limits.
On day 9 the patient underwent surgical debridement by a plastic surgeon. Necrotic tissue was removed under the left eye and from the left upper eyelid. He recovered fully, underwent several more debridements, and had a skin graft on day 20.
Case 2
A 7yearold boy was bitten on the face by a zebra snake, which also spat in his eyes, at 01h30 while asleep in his bed. He and his family were on holiday in Namibia, staying at a lodge in the north western part of the country. He was immediately taken to the local clinic, where his eyes were thoroughly rinsed with saline and where he erroneously received 10 mL SAVP polyvalent antivenom intravenously.
The patient was transferred to Windhoek, where he was admitted at ~11h00 under the care of the local snakebite expert. The bite was in the left infraorbital region, and severe bilateral periorbital oedema was present: he could not open his eyes. The swelling extended to the left side of the face and neck, with a 2 × 3.5 cm blue discoloured area of skin around the bite. He was fully awake and well orientated, but extremely irritable and complaining of severe muscle pains involving his entire body. His blood pressure, pulse rate, oxygen saturation and temperature were all within normal limits. There was no evidence of muscle weakness, but he exhibited signs of hyperaesthesia. Both lungs aerated well and there was no stridor or respiratory distress. An ophthalmologist was consulted.
Owing to concern of possible airway obstruction as a result of the severe swelling of the face and neck, the patient was transferred for observation to the intensive care unit (ICU). He was treated with maintenance intravenous fluids, amoxicillinclavulanic acid, tilidine, paracetamol, diclofenac and dexamethasone. Blood samples for a full blood count, U&E, liver function tests (LFTs), CK and a clotting profile were sent to the laboratory, and dipstick urinalysis was requested.
Approximately 15 hours after having been bitten, the patient suddenly developed a sinus tachycardia (180 bpm), followed by a tonicclonic convulsion. The convulsion lasted 5 minutes and terminated spontaneously. The patient was lethargic immediately after the convulsion, with increased peripheral reflexes and neck stiffness. An urgent CT scan showed no intracranial bleeding or structural abnormalities. At this stage a physician was consulted to join the team of specialists managing the patient. Intravenous sodium valproate was initiated. No further convulsions occurred and the tachycardia subsided spontaneously over the next hour.
Abnormal results of initial special investigations were as follows: dipstick urinalysis 3+ positive for blood, WBC 31.4 × 10 9 /L (neutrophil count 25.4 × 10 9 /L), INR 1.5 (normal 0.9 1.3), CK 2 090 U/L, AST 118 U/L, unconjugated bilirubin 73 μmol/L and LD 793 U/L. 
IN PRACTICE
The patient was kept in the ICU for monitoring of his vital signs. Intravenous fluids were pushed to maintain a urinary output of 2 mL/ kg/h. Vitamin K and freshfrozen plasma were given preoperatively on day 2 and clindamycin was added. Daily special investigations (FBC, U&E, LFTs, CK and clotting profile) were done until the patient stabilised. CK values increased until day 3 with a peak of 17 360 U/L. The INR peaked on day 2 (1.8) and the WBC decreased from 31.4 × 10 9 /L on admission to 11.9 × 10 9 /L on day 6.
Hb decreased from 15.1 g/dL on admission to 11.9 g/dL on day 7. Kidney function and electrolyte values stayed within normal limits. Cumulative results are shown in Table 2 .
On day 3 a plastic surgeon performed debridement of all discernible necrotic tissue. Ophthalmological examination under anaesthesia revealed no injury to the left eye but a possible completely healed corneal lesion on the right, probably caused by the venom that had been spat into the eye. A further debridement with insertion of a Crawford tube into the left lacrimal duct was done on day 5. Spreading of the necrosis necessitated additional debridement on days 7 and 9. Swelling of the neck and face only started to resolve after day 5.
On day 10 the patient's condition was considered stable and he was transferred to the care of a plastic surgeon in South Africa, where he had several more debridements and a skin graft.
Case 3
A 20monthold baby was bitten on the left occiput by a zebra snake at 06h00 while sleeping on the floor at home, 15 km outside Okahandja, a small town 71 km north of Windhoek. The snake (a 1.4 m juvenile male) was killed and brought along for identification. Prior to transfer to Windhoek, the patient erroneously received 2 ampoules of SAIMR polyvalent antivenom at the local hospital.
The patient, irritable and with a raised pulse and blood pressure, arrived in Windhoek 10 hours after being bitten. The bite area was moderately swollen with blue discoloration. After being admitted under the care of a pediatrician in the ICU, an emergency debridement was done ~11 hours after the bite.
Initial blood results showed a low Hb (9.6 g/dL), a raised WBC (18.2 × 10 9 /L) and neutrophilia (16.2 × 10 9 /L). AST, ALT and LDH were elevated. Serum myoglobin was raised and the INR was 1.
A peripheral blood smear revealed polychromasia, burr cells and anisopoikilocytosis (CK was not done on admission).
On day 2 the patient became drowsy, urine output dropped to <1 mL/kg/h, and the serum urea level increased to 8.6 mmol/L (normal 2.9 8 .2 mmol/L). This occurred in spite of aggressive fluid management. Furosemide was added. The INR increased to 3.2 despite administration of freshfrozen plasma and vitamin K. The Hb fell to 6.5 g/dL, and packed red cells were transfused.
During day 3, urine output responded to treatment and the INR normalised with further vitamin K and plasma. On the evening of day 3, the patient developed respiratory distress because of severe swelling. An emergency tracheostomy was performed and a large haematoma was drained from the bite area. The CK peaked on day 2 at 75 000 U/L and was <500 U/L on day 8. LDH remained high until day 4 before starting to subside. Cumulative results are shown in Table 3 .
The patient required several debridements for a large necrotic area on the scalp. Skin grafts were done by a plastic surgeon after 2 weeks. All parameters returned to normal and the patient was discharged after 3 weeks.
Discussion
Snake venom is highly modified saliva that contains a complex mixture of proteins, enzymes and other substances with toxic and lethal properties. Envenomation can produce neurotoxic, cytotoxic, haemotoxic, myotoxic and cardiotoxic symptoms, presenting as a single symptom complex or in any combination, depending on the composition of the venom. [18, 19] The majority of recorded bites by N. n. nigricincta were inflicted on the victim's extremities. The snake's fangs are relatively short (~3 mm) with the venom opening proximal to the tip. [7] One can speculate that in a bite on an extremity, the venom is usually injected into the subdermal layer between the skin and muscle. Owing to the low vascularity of this area, minimal or no systemic absorption occurs and only necrotising signs may develop. Bites on the face, directly intravascular or in cases of high venomtobody ratio (e.g. babies and small children) will result in venom absorption into the circulation with systemic envenomation.
Intravascular haemolysis occurs from snake envenomation as a result of the action of phospholipase A 2 , which is present in almost all snake venoms, and a basic protein called direct lytic factor, found only in elapid venoms. [19] With lysis of the red blood cells, haemoglobin is released into the bloodstream and is immediately bound by haptoglobin. [20] If the haemolysis is beyond the reabsorptive capacity of the haptoglobin, excess haemoglobin is filtered by the kidney and results in haemoglobinurea and urine haemosiderin. [21] Lysis of red cells causes anaemia [20] and haem promotes neutrophil Rhabdomyolysis is a common consequence of snake envenomation. Myotoxic phospholipases A 2 in the venom bind to acceptors in the plasma membrane, initiating a series of complex degenerative events culminating in the dispersion of muscle constituents into the circulation. [25, 26] Large quantities of potassium, phosphate, myoglobin, aldolase, CK, LDH, AST and purines leak into the circulation. Myoglobin in the renal filtrate can cause renal tubular damage by several mechanisms. [22, 25, 2729] Proteases released from muscle injury cause hepatic dysfunction. [30] Hyperkalaemia, hypocalcaemia and hepatic inflammation are early complications, late complications being renal failure and diffuse intravascular coagulation probably caused by the activation of the clotting cascade by components released from the damaged muscles. [25, 29] Our patients exhibited leukocytosis, very high CK values (peaking 2 3 days after the bite), raised serum myoglobin, low serum haptoglobin, raised AST, ALT and LDH, and an increased INR. Patient 3 also exhibited polychromasia, burr cells and anisopoikilocytosis on peripheral blood smears. A decrease in Hb was common.
A definitive diagnosis of rhabdomyolysis was made on the grounds of the serum CK being more than five times the normal value, and the presence of urine or serum myoglobin. The decrease in Hb, leukocytosis and peripheral smear features are more specific for haemolysis. Increased AST, LDH and unconjugated bilirubin, low serum haptoglobin and positive urine dipstick for blood overlap for both intravascular haemolysis and rhabdomyolysis. [2123, 2536] These rhabdomyolytic and intravascular haemolytic effects of N. n. nigricinta venom have not been recorded previously. [31] A recent study by Bittenbinder et al. [32] demonstrated inhibition of both factor Xa and thrombin by the venom of N. n. nigricinta. Whether the transient rise in the INR was the result of the direct toxic effects of the venom on the clotting cascade, or of disseminated intervascular coagulation secondary to rhabdomyolysis, needs further research. [22, 33] Additionally, the drowsiness and convulsion seen in our two younger patients may reflect neurotoxic symptoms due to the high venomto mass ratio in smaller victims. [37] Although the toxic composition of snake venom varies between species and even within the same species, [18, 19, 27] we hope that publishing these case studies will rekindle interest in and awareness of the systemic effects of envenomation by African spitting cobras, resulting in speciesspecific research.
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